Improved diagnosis of SARS-CoV-2 by using Nucleoprotein and Spike protein fragment 2 in quantitative dual ELISA tests
View ORCID ProfileCarolina De M. Verissimo, Carol O’Brien, Jesús López Corrales, Amber Dorey, Krystyna Cwiklinski, Richard Lalor, Jack M. Doyle, Stephen Field, Claire Masterson, Eduardo Ribes Martinez, Gerry Hughes, Colm Bergin, Kieran Walshe, Bairbre McNicholas, John G. Laffey, John P. Dalton, Colm Kerr, Sean Doyle
doi: https://doi.org/10.1101/2021.04.07.21255024
Carolina De M. Verissimo
1Molecular Parasitology Lab (MPL) - Centre for One Health and Ryan Institute, School of Natural Science, National University of Ireland Galway, Galway, Republic of Ireland
Carol O’Brien
2Department of Biology - National University of Ireland Maynooth, Maynooth – Ireland
Jesús López Corrales
1Molecular Parasitology Lab (MPL) - Centre for One Health and Ryan Institute, School of Natural Science, National University of Ireland Galway, Galway, Republic of Ireland
Amber Dorey
1Molecular Parasitology Lab (MPL) - Centre for One Health and Ryan Institute, School of Natural Science, National University of Ireland Galway, Galway, Republic of Ireland
Krystyna Cwiklinski
1Molecular Parasitology Lab (MPL) - Centre for One Health and Ryan Institute, School of Natural Science, National University of Ireland Galway, Galway, Republic of Ireland
Richard Lalor
1Molecular Parasitology Lab (MPL) - Centre for One Health and Ryan Institute, School of Natural Science, National University of Ireland Galway, Galway, Republic of Ireland
Jack M. Doyle
2Department of Biology - National University of Ireland Maynooth, Maynooth – Ireland
Stephen Field
3Clinical Associate Professor (TCD), Medical and Scientific Director, Irish Blood Transfusion Service, Dublin, Ireland
Claire Masterson
4School of Medicine, and Regenerative Medicine Institute (REMEDI) at CÚRAM Centre for Research in Medical Devices, Biomedical Sciences Building, National University of Ireland Galway, Galway, Ireland
Eduardo Ribes Martinez
4School of Medicine, and Regenerative Medicine Institute (REMEDI) at CÚRAM Centre for Research in Medical Devices, Biomedical Sciences Building, National University of Ireland Galway, Galway, Ireland
Gerry Hughes
5School of Medicine, Trinity College Dublin, College Green, Dublin 2, Ireland
6Department of Infectious Diseases, St James’s Hospital, James’s Street, Dublin 8, Ireland
Colm Bergin
5School of Medicine, Trinity College Dublin, College Green, Dublin 2, Ireland
6Department of Infectious Diseases, St James’s Hospital, James’s Street, Dublin 8, Ireland
Kieran Walshe
2Department of Biology - National University of Ireland Maynooth, Maynooth – Ireland
Bairbre McNicholas
7Department of Anaesthesia and Intensive Care Medicine, University Hospital Galway, Saolta University Hospital Group, Galway Ireland
John G. Laffey
4School of Medicine, and Regenerative Medicine Institute (REMEDI) at CÚRAM Centre for Research in Medical Devices, Biomedical Sciences Building, National University of Ireland Galway, Galway, Ireland
John P. Dalton
1Molecular Parasitology Lab (MPL) - Centre for One Health and Ryan Institute, School of Natural Science, National University of Ireland Galway, Galway, Republic of Ireland
Colm Kerr
5School of Medicine, Trinity College Dublin, College Green, Dublin 2, Ireland
6Department of Infectious Diseases, St James’s Hospital, James’s Street, Dublin 8, Ireland
Sean Doyle
2Department of Biology - National University of Ireland Maynooth, Maynooth – Ireland
Posted April 09, 2021.
Improved diagnosis of SARS-CoV-2 by using Nucleoprotein and Spike protein fragment 2 in quantitative dual ELISA tests
Carolina De M. Verissimo, Carol O’Brien, Jesús López Corrales, Amber Dorey, Krystyna Cwiklinski, Richard Lalor, Jack M. Doyle, Stephen Field, Claire Masterson, Eduardo Ribes Martinez, Gerry Hughes, Colm Bergin, Kieran Walshe, Bairbre McNicholas, John G. Laffey, John P. Dalton, Colm Kerr, Sean Doyle
medRxiv 2021.04.07.21255024; doi: https://doi.org/10.1101/2021.04.07.21255024
Improved diagnosis of SARS-CoV-2 by using Nucleoprotein and Spike protein fragment 2 in quantitative dual ELISA tests
Carolina De M. Verissimo, Carol O’Brien, Jesús López Corrales, Amber Dorey, Krystyna Cwiklinski, Richard Lalor, Jack M. Doyle, Stephen Field, Claire Masterson, Eduardo Ribes Martinez, Gerry Hughes, Colm Bergin, Kieran Walshe, Bairbre McNicholas, John G. Laffey, John P. Dalton, Colm Kerr, Sean Doyle
medRxiv 2021.04.07.21255024; doi: https://doi.org/10.1101/2021.04.07.21255024
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (712)
- Anesthesia (204)
- Cardiovascular Medicine (2965)
- Dermatology (250)
- Emergency Medicine (444)
- Epidemiology (12785)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4610)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2939)
- Health Policy (1070)
- Hematology (392)
- HIV/AIDS (927)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4392)
- Nursing (237)
- Nutrition (646)
- Oncology (2284)
- Ophthalmology (650)
- Orthopedics (259)
- Otolaryngology (327)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (501)
- Public and Global Health (6982)
- Radiology and Imaging (1539)
- Respiratory Medicine (917)
- Rheumatology (443)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)